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Abstract
From computational simulations of a serotonin 2A receptor (5-HT2AR) model complexed with pharmacologically and
structurally diverse ligands we identify different conformational states and dynamics adopted by the receptor bound to the
full agonist 5-HT, the partial agonist LSD, and the inverse agonist Ketanserin. The results from the unbiased all-atom
molecular dynamics (MD) simulations show that the three ligands affect differently the known GPCR activation elements
including the toggle switch at W6.48, the changes in the ionic lock between E6.30 and R3.50 of the DRY motif in TM3, and
the dynamics of the NPxxY motif in TM7. The computational results uncover a sequence of steps connecting these
experimentally-identified elements of GPCR activation. The differences among the properties of the receptor molecule
interacting with the ligands correlate with their distinct pharmacological properties. Combining these results with
quantitative analysis of membrane deformation obtained with our new method (Mondal et al, Biophysical Journal 2011), we
show that distinct conformational rearrangements produced by the three ligands also elicit different responses in the
surrounding membrane. The differential reorganization of the receptor environment is reflected in (i)-the involvement of
cholesterol in the activation of the 5-HT2AR, and (ii)-different extents and patterns of membrane deformations. These
findings are discussed in the context of their likely functional consequences and a predicted mechanism of ligand-specific
GPCR oligomerization.
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Introduction
Serotonin 2A receptors (5-HT2AR) are a very well characterized
family of G-protein coupled receptors (GPCRs) in the amine sub-
class of rhodopsin-like class A GPCRs [1,2]. The 5-HT2ARs are
targeted by chemically and pharmacologically distinct classes of
ligands which include antidepressants, anxiolytics, antiemetics,
antipsychotics and anti-migraine agents. Notably, some agonists
exhibit hallucinogenic properties [2,3] that have been attributed to
specific manners of activation of these receptors [4,5]. Even when
they share key structural features, such as the indole moiety of the
non-hallucinogen 5-HT and the hallucinogen LSD, the 5-HT2AR
ligands have been shown to be able to bind differently to the
receptor molecule, and to exhibit different pharmacological
properties [2,6,7,8]. Understanding the relation between the
different modes of binding of structurally diverse compounds in
the 5-HT2AR binding site, and the pharmacological responses they
elicit, has therefore been of great interest in the quest for
understanding the function of the 5-HT2AR and especially its role
in hallucinogenesis [5]. Important clues came from in vivo studies
demonstrating that behavioral responses to different 5-HT2AR
ligands correlate with distinct transcriptome fingerprints for the
ligands [4]. However, while it remains unclear how ligand binding
induces distinct conformational states of the 5-HT2AR, and
how this can result in different pharmacological outcomes [5],
the significant variability in receptor conformations that can be
induced by different ligands has recently been demonstrated for
the cognate b2-adrenergic receptor [9].
Structural evidence for differential effects of the GPCR ligands
in relation to receptor function should be reflected in the
variability of rearrangements in the key structural elements
involved in the various activation states of the receptors, e.g.,
the structural motifs/functional microdomains (SM/FMs) [10]
(see Figure 1A) that characterize GPCR activation [5,11,12,13].
Specific SM/FMs have been reported from studies of a large
variety of GPCRs [10,14,15,16,17], and their dynamic signatures
include (i)-the flipping of the toggle switch W6.48 (Trp336,
identified here by the Ballesteros-Weinstein generic numbering
[18]) in the cluster of conserved aromatic residues in TM5 and
TM6, (ii)-the opening/closing of the ionic lock between the DRY
motif (D3.49–R3.50–Y3.51) and E6.30, involved in the movement
of the intracellular (IC) end of TM6 away from TM3, and (iii)-the
dynamics of the conserved NPxxY motif at the IC end of TM7
that connects as well to H8. These are elements of activation
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their status in the X-ray structures of various GPCRs has been
evaluated [12,20,21,22,23,24,25]. It is still unclear, however, how
the binding of different ligands affects these elements of GPCR
activation and how they connect to the mechanisms of the ligand-
driven receptor oligomerization that has been shown to be critical
for GPCR function [26,27,28,29,30,31].
To shed new light on these central mechanistic questions from
the perspective of ligand-dependent conformational states involved
in the activation and oligomerization of GPCRs in their mem-
brane environment, we performed large-scale molecular dynamics
(MD) simulations of 5-HT2AR in complex with ligands exhibiting
different pharmacological properties: the full agonist 5-HT, the
partial agonist LSD, and the inverse agonist Ketanserin (KET)
(Figure 2A). The simulation results show that the three ligands
affect differently the dynamics of SM/FMs monitored in the
simulations (Figure 1B), which achieve distinct conformations that
are consistent with the pharmacological classification of these
ligands. Moreover, the simulations show that the ligand-bound
GPCRs produce differential responses in the lipid membrane
surrounding the receptor, as reflected in the spatial pattern of the
remodeling of membrane thickness. These trajectories reveal as
well the modes and effects of direct receptor-cholesterol interac-
tion. Recently we have described the development and imple-
mentation of a new method, CTMD (Combined conTinuum and
Molecular Dynamics), for quantitative analysis of the membrane
remodeling pattern based on MD trajectories [32]. With this
method we account for both the membrane remodeling energy
and the energy cost of any partial (incomplete) alleviation of the
hydrophobic mismatch by this remodeling of the membrane.
From the quantitative analysis with CTMD of the simulation
results for the monomeric 5-HT2AR we identified ligand-specific
local membrane perturbations that can produce different patterns
of 5-HT2AR oligomerization driven by hydrophobic mismatch
[32]. Our results lead to the prediction that the dimerization
interfaces for 5-HT2AR oligomers will be different when the
receptor binds ligands with different pharmacological properties
(inverse agonist, partial agonist, or agonist), as suggested earlier
[27]. Notably, the extent of membrane-driven oligomerization of a
5-HT2AR in the inverse agonist-bound state is predicted to be
larger than in the agonist-bound state. These predictions are
consistent with previous experimental findings on cognate GPCRs
[27,28,31], supporting the link we identify here between ligand-
dependent conformational changes in GPCRs and differences in
local membrane perturbations.
Results
Agonist-determined dynamics are expressed as an
ordered sequence of changes in the SM/FMs of ligand-
bound 5-HT2AR
The main dynamic rearrangements observed in the simulations
of the 5-HT2AR when it binds each of the ligands, are described
Figure 1. The position and dynamic sequence of Structural Motifs recognized as Functional Microdomains (SM/FMs) in the
molecular model of the 5-HT2AR. (A) Known structural elements of GPCR activation (SM/FM) in the homology model of the 5-HT2AR.( B) The
time-ordered sequence of events identified from the MD simulations of the agonist-bound 5-HT2AR.
doi:10.1371/journal.pcbi.1002473.g001
Author Summary
The 5-HT2A receptor for the neurotransmitter serotonin (5-
HT) belongs to family A (rhodopsin-like) G-protein coupled
receptors (GPCRs), one of the most important classes of
membrane proteins that are targeted by an extensive and
diverse collection of external stimuli. Recently we learned
that different ligands targeting the same GPCR can elicit
different biological responses, but the mechanisms remain
unknown. We address this fundamental question for the
serotonin 5-HT2A receptor, because it is known to respond
to the binding of structurally diverse ligands by producing
similar stimuli in the cell, and to the binding of quite
similar ligands with dramatically different responses.
Molecular dynamics simulations of molecular models of
the serotonin 5-HT2A receptor in complex with pharmaco-
logically distinct ligands show the dynamic rearrange-
ments of the receptor molecule to be different for these
ligands, and the nature and extents of the rearrangements
reflect the known pharmacological properties of the
ligands as full, partial or inverse activators of the receptor.
The different rearrangements of the receptor molecule are
shown to produce different rearrangements of the
surrounding membrane, a remodeling of the environment
that can have differential ligand-determined effects on
receptor function and association in the cell’s membrane.
Ligand-Dependent Differences in 5-HT2AR States
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family of GPCRs [5]. The sequential order of the description is
determined by the order in which these changes appear in the
simulation trajectories of the 5-HT2AR bound to the full agonist 5-
HT (Figure 1B).
TM6 and the ionic lock. Figure 1 illustrates the known
structural characteristics of GPCR activation and the time-ordered
sequence of their occurrence in the simulation of the 5-HT-bound
5-HT2AR. The time-dependent changes in these SM/FMs are
detailed in Figure 3. During the initial stages of the simulation, the
changes in the orientation of the TM6 segments (before and after
the Proline-kink) cause the bend to straighten out (Figure 3A) and
the extracellular (EC) end of TM6 to move toward TM3 (Figure 3B
and G). This is consistent with a conformational change observed
in the crystal structure of b2AR [25] as well as in experiments [33]
associated with b2AR activation. It is interesting to note that the
change in bend angle around P6.50, from 33.2 in the inactive
b2AR (2RH1_chain A) to 25.9 in the active b2AR (3SN6_chain
R), is consistent with the first changes observed in the simulation of
5-HT-bound 5-HT2AR (Figure 3). In addition, the ionic lock
(between the DRY motif on the IC end of TM3 and E6.30)
changes as shown in Figure 3E: it equilibrates first into a closed
form, but in later stages of the trajectory switches back to an
open form compatible with the expected agonist-activated
conformation; the IC end of TM6 moves away from TM3
(Figure 3D, I). This is remarkable because of the opening of the
ionic lock between the DRY motif and E6.30 is a landmark of
GPCR activation [10,34,35,36,37], and the broken ionic lock is
evident in an active b2AR structure stabilized by nanobody [23] as
well as an agonist-bound b2AR in complex with the nucleotide
free Gs heterotrimer [25].
The aromatic cluster. From the trajectory, the opening of
the ionic lock (Figure 3E) and the movement of the IC end of TM6
(Figure 3D) appear to relate to the rotamer flip of W6.48 from its
orientation near-perpendicular to the membrane plane, to a near-
parallel one (Figure 3C, J). Such a conformational switch in W6.48
upon GPCR activation has been reported from a variety of
experimental studies [36,38], and is observed near the 140 ns time
point in the trajectory when the x1 angle of W6.48 changes from g-
to trans (Figures 1B,3C,3J). When the ring of W6.48 remains
parallel to the bilayer for ,1 ns it forms a double pi-pi interaction
with both F6.44 and F6.51 (see Figure S1 in Text S1). This may
facilitate the change in TM6 kink around P6.50 as suggested
earlier [39] which would thus support the opening of the ionic lock
by increasing the distance between the IC ends of TM6 and TM3
(Figure 3D).
The NPxxY motif and helix 8. During the first 50 ns of the
agonist-bound 5-HT2AR simulation, the conserved NPxxY motif
at the IC end of TM7 changes its conformation and spatial
relation to H8 (Figure 3F). The dynamics in this SM/FM have
been related to GPCR activation [19,22]. In particular, the
interdependence of residues at positions 7.53 and 7.60 in the
Figure 2. Structures of ligands with different efficacy and their interactions with 5-HT2AR during MD simulations. (A) Chemical
structures of 5-HT, LSD and KET. Amines interacting with D3.32, S3.36 or S5.46 [6,7,116,117,118,119] are labeled. (B,C,D) Docking poses in the initial
structures (left panels) and during the simulations (right panels) for 5-HT (B), LSD (C) and KET (D), respectively. For clarity, only TM 3, 5 and 6 are
shown in grey ribbons. Sidechains of residues D3.32, S3.36, S5.43, S5.46, F5.47, F6.44, W6.48, F6.51, F6.52 and N6.55 are depicted as sticks, and 5-HT
(carbons colored in orange), LSD (cyan) and KET (green) are rendered in spheres. Note that, due to its large-size, and because its quinazoline ring
penetrates deep into the binding pocket close to W6.48, KET is in direct contact with all the residues in the aromatic cluster, including F5.47. (E) Time-
evolution of backbone TM RMSDs of 5-HT2AR( upper panel) and of the distances between the carboxyl/hydroxyl oxygens in D3.32, S3.36 and S5.46 on
5-HT2AR and their interacting amine nitrogens on ligands (see panel A) during the simulations (lower panels). Traces are shown in orange for 5-HT, in
cyan for LSD, and in green for KET. Data were collected every 100 ps. Running averages were calculated every 10 data points and are shown in bold
shades. Na atom of 5-HT maintains a salt-bridge with D3.32 and forms an H-bond with S3.36 (Figure S2 in Text S1); N1 atom of 5-HT forms an H-bond
with S5.46 either directly or through a water-bridge.
doi:10.1371/journal.pcbi.1002473.g002
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the active state in the serotonin 2C receptor (5-HT2CR) [24], and
structural data show that the pi-pi interaction between 7.53 and
7.60 (Figure 1A) seen in inactive structures, is disrupted in active
structures of b2AR stabilized by nanobody [23], or complexed
with the Gs heterotrimer [25]. In addition, the Ca distances
between 7.53 and 7.60 in these active structures are larger (9.6 ???)
than those in inactive ones (6.3 ???). The opening of the TM7-H8
angle is consistent with the transition to activated states of other
GPCRs [22], and here we find that, in the 5-HT-bound 5-HT2AR,
H8 moves away from TM7 and the distance between the Ca
atoms of Y7.53 and Y7.60 increases from ,6.2 ??? during the first
50 ns, to a value of 8 A ˚ that remains stable for the remainder of
the trajectory (Figure 3F).
Taken together, this sequence of steps observed in our simulations of 5-
HT2AR in complex with 5-HT (Figure 1B) not only captures structural
effects of agonist binding on the status of the SM/FMs, but also provides a
mechanistically understandable hypothesis for this ordered sequence of
apparently interrelated conformational changes that bring the 5-HT-bound
5-HT2AR in line with known features of the activated state.
Significant differences are evident in the dynamics of the
same SM/FMs in 5-HT2AR bound to either the partial
agonist LSD or the inverse agonist KET
Comparison of results in Figure 4 with Figure 3 brings to light
the differences among the dynamic mechanisms connected with
the binding of the three different ligands to the 5-HT2AR, as
detailed below.
KET bound to the 5-HT2AR. In the KET simulation, the
initially open ionic lock closes around 200 ns, and remains closed
for the remainder of the trajectory, as the Ca distance between
R3.50 and E6.30 residues stabilizes below 9 A ˚ (Figure 4D, right
panel), i.e., at a value consistent with inactive conformations of
Figure 3. Activation steps of 5-HT2AR bound with 5-HT. (A) Evolution of the bend angle in TM6 around P6.50, highlighting the intervals during
which the helix straightens (event 1) and bends (event 3) upon activation. (B) Evolution of the Ca distances between D3.32 and F6.52 (red), and
between D3.32 and N6.55 (black), illustrating the interval during which the EC end of TM6 moves towards TM3 (event 2). (C) Evolution of the tilt angle
of the toggle switch W6.48 aromatic ring with respect to the membrane normal, showing the time point of W6.48 flipping (event 4). W6.48 becomes
parallel to the membrane for ,1 ns at 143 ns (see panel J) with x1 angle changing from g- to trans.( D) Evolution of the Ca distance between D3.32
and V6.40 illustrating the interval when the IC end of TM6 moves away from TM3 (event 5). (E) Dynamics of the ionic lock presented as the evolution
of the Ca distance between R3.50 and E6.30. Initially broken ionic lock forms during the first 50 ns, before opening again upon activation at ,170 ns
(event 6). (F) Evolution of the Ca distance between Y7.53 and Y7.60. (G) Snapshots from the membrane plane and the EC end, highlighting positions
of D3.32 and N6.55 and the distance between them, and showing the initial straightening and motion of TM6 towards TM3 (event 1). Gray cartoon
represents the starting structure, and the orange cartoon is the structure averaged over the 83–112 ns interval. (H) Cartoon representation of TM3
and TM6 highlighting the kink in the TM6 that occurs in the 135–225 ns time interval (event 3). Orange and Magenta cartoons represent structures
averaged over 83–112 ns and 290–350 ns, respectively. (I) Snapshots of TM3 and TM6 depicting positions of R3.50 and E6.30 residues and the
distance between them and illustrating the movement of TM6 away from TM3 (event 5). Color code is the same as in panel G.( J) Detailed dynamics
in the toggle switch W6.48. Evolution of the x1 and x2 angles is shown during the 140–146 ns time-interval when the toggle switch flips. Also shown
are the snapshots at 0 ns and 143 ns time-points of the 5-HT and W6.48 (in spheres and colored by atom type, 5-HT in orange, and W6.48 in grey and
cyan at 0 ns and 143 ns, respectively.).
doi:10.1371/journal.pcbi.1002473.g003
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this SM/FM in an inactive form of the receptor, is the observation
in KET-bound 5-HT2AR that neither the bend angle in TM6
(Figure 4A, right panel), nor the rotamer status of W6.48 (Figure 4C,
right panel), change as they were seen to do in the trajectory of the
5-HT-bound receptor (Figure 3A, 3C). Thus, TM6 is more kinked
with KET in the binding site than with 5-HT bound in the 5-
HT2AR, but no movement of the EC end of TM6 is observed
relative to TM3 (Figure 4B, right panel). This is in sharp contrast to
the behavior of 5-HT-bound receptor (Figure 3B), where
significant changes in these activation elements were observed.
Further, the dynamics of the NPxxY motif is also different in the
KET-bound receptor, with the TM7-H8 pair maintaining a
tighter conformation, and the Y7.53-Y7.60 Ca distance stabilized
at ,6A ˚ for the later part of the trajectory (Figure 4E), i.e., 2 A ˚
shorter than that in 5-HT2AR complexed with 5-HT (Figure 3F).
Note that such close proximity of the Y7.53 and Y7.60 residues
has been suggested as a characteristic of an inactive state in
GPCRs [41].
To validate the inferences from the KET simulation, and verify
the distinctions between the agonist-bound and inverse-agonist
bound forms of the 5-HT2AR, we tested whether the binding of
the inverse agonist KET would reverse the effect of the full agonist
5-HT on the conformational state of the serotonin receptor. To
this end, we used the 5-HT-bound 5-HT2AR structure (from the
average over the 300–350 ns trajectory interval of the simulation)
as a starting structure for a new 500 ns simulation in which KET
was substituted for the 5-HT (termed, KET-substituted, see
Methods). As illustrated in Figure 5A, at ,240 ns into this new
trajectory, the ionic lock that had opened in the agonist-bound
simulation started to close when KET replaced it (the E6.30–
R3.50 Ca distance decreased below 9 A ˚), and D3.49 and R3.50
formed a salt-bridged H-bond. Furthermore, from the same time
point onwards, the structure of the TM bundle gradually became
more similar to that stabilized by KET (the backbone TM RMSD
relative to the KET-stabilized structure decreased by ,0.5 A ˚;
Figure 5A).
These results show that the SM/FMs in the 5-HT2AR bound to KET
adopt characteristics observed in inactive GPCR states, which differ
significantly from the ones observed with 5-HT in the binding site. This
observation is in line with the opposite pharmacological properties of these two
ligands.
LSD bound to the 5-HT2AR. As shown in Figure 4 (left panel),
the dynamic behavior of the LSD-bound receptor is in line with
the pharmacological efficacy of LSD as a partial agonist, i.e.,
intermediate between those observed for the 5-HT- and KET-
bound 5-HT2AR constructs. Thus, in the LSD-bound receptor the
ionic lock transitions between open and closed conformations
(Figure 4D, left panel), as the R3.50–E6.30 distance fluctuates in the
range of values proposed [40] for open (.9A ˚) and closed (,9A ˚)
Figure 4. Dynamics of activation elements in LSD- and KET-bound 5-HT2AR. (A–E) Left and right panels show the evolution of active state
components in the 5-HT2AR complexed with LSD and KET, respectively (for details see Figure 3). (F) Cartoon representation of TM3 and TM6 in the
structures averaged over the last 100 ns of the LSD (cyan) and KET (green) trajectories, showing positions of R3.50 and E6.30 residues (in sticks).
doi:10.1371/journal.pcbi.1002473.g004
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distance in the LSD-bound receptor remains in the range
associated with an open conformation throughout the trajectory,
similar to that in the 5-HT bound receptor (cf. Figures 3F and 4E).
The bend angle around P6.50 in the LSD-bound receptor
decreases from 35u to 15u (Figure 4A, left panel) with the EC end
of TM6 bending towards the center of the protein bundle.
However, the extracellular segment of TM6 does not come as
close to TM3 as it does in the 5-HT simulation (cf. D3.32-F6.52
and D3.32-N6.55 in Figure 3B and Figure 4B, left panel).
Consistent with the incomplete opening of the ionic lock, the
time-trace of the tilt angle of the W6.48 aromatic ring in LSD
trajectory (Figure 4C, left panel) indicates as well that the dynamics
of the toggle switch is intermediate: the complete flipping of
W6.48, observed in the 5-HT simulation (Figures 3C, 3J), is
replaced here by significant fluctuations in W6.48 orientation
compared to the KET-bound 5-HT2AR (Figure 4C, right panel).
Thus, in monitoring the steps in the dynamic sequence we find for the partial
agonist LSD a series of intermediate dynamic modes that turn on the SM/FM
forms associated with an active conformation, but not necessarily all of them
together (e.g., the TM7-H8 angle is wider, and the ionic lock is broken, but
with a fluctuating, not flipped W6.48). Like the other two ligand types, the
pattern generated by LSD is entirely consistent with its known pharmacological
property.
The 5-HT2AR in complex with either 5-HT, LSD, or KET
visits distinct conformational spaces
The nature of similarities and differences observed in the
dynamics of the 5-HT2AR when it binds each of the three ligands
was further evaluated with Combined Essential Dynamics (Comb-
ED, see Methods) [42] performed on concatenated trajectories for
5-HT&LSD, 5-HT&KET, and LSD&KET, each combining the
last 100 ns of the individual trajectories for the pair. The
comparison of such combined trajectories by their projection
along their first and second eigenvectors is shown in Figure 6A,
which illustrates the differences in the conformational spaces
sampled by the 5-HT2AR bound to different ligands. Clearly,
along the first eigenvector, the conformational spaces sampled by
the 5-HT-bound and LSD-bound receptor are seen to be more
similar to each other than either one is to the space sampled by
KET-bound 5-HT2AR (note that the first and second eigenvectors
are different in each plot because the concatenated trajectories
differ, so that the sampled spaces shown in the plots for any one
ligand-bound receptor appear at different positions).
The comparison in Figure 6B–C shows the differences in a
structural context by indicating where the largest differences
occur, as monitored by the magnitudes of the projections on the
first eigenvectors (color coded from red, green to blue representing
magnitudes from large, median to small, respectively). Also evident
in this figure is the greater similarity between the dynamics of the
5-HT and LSD-bound receptors (Figure 6B–C, top panel). Comb-
ED analysis identifies only insignificant differences between the
agonist- vs. partial agonist-bound states of the receptor, with some
variations in the positioning of the juxta-membrane H8 and in
TM4 (Figure 6B–C, top panel). However, the structure of 5-HT2AR
in complex with either 5-HT or LSD is clearly distinct from that
with KET bound, as seen in Figure 6B–C where the Comb-ED
detects differences in TM5–6 (linked by IL3) and TM4 in the 5-
HT vs. KET comparison (middle panel), and LSD vs. KET (bottom
panel).
Differences between 5-HT2AR complexes with the inverse
agonist, and those with the agonists 5-HT or LSD, are apparent as
well for TM1, TM3 and H8 (Figure 6B–C, middle and bottom panels).
Thus, in the KET-bound receptor, Comb-ED identifies the
movement of TM5 and TM6 toward TM3 at the IC end,
consistent with the observed closing of the ionic lock in the inverse
agonist state (Figure 4D,F, right panel). Furthermore, differences are
evident at the EC end of TM6 between KET- and 5-HT-induced
conformations, in agreement with the different level of kink in
TM6 around the P6.50 in the two systems (compare Figures 3A
and 4A). In addition, in line with the observed differences in the
dynamics of NPxxY motif (Figures 3F and 4E), the Comb-ED
analysis in the KET-bound receptor detects the motion of H8
toward TM7 to close the angle between them, consistent with
earlier studies of cognate GPCRs [22,37,43].
Based on the Comb-ED results suggesting structural differences
as well in TM1 and TM4 between the states of 5-HT2AR
Figure 5. Characteristic dynamics of 5-HT2AR induced by 5-HT are reversed by KET. (A) Evolution of the TM backbone RMSD of KET-
substituted receptor compared to KET-bound receptor, averaged along 250–350 ns (top), the minimum distance between the carboxylate oxygens of
D3.49 and the guanidine nitrogens of R3.50 (middle), as well as the Ca distance between R3.50 and E6.30 (bottom). (B) Extreme projections along the
first eigenvector from Comb-ED analysis of the combined 5-HT-bound and KET-substituted receptors (left panel), as well as KET-bound and KET-
substituted (right panel) trajectories. The receptor is shown in tubes, and colors depict magnitudes of conformational changes from small to large
(from blue to green, and to red).
doi:10.1371/journal.pcbi.1002473.g005
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levels of tilt in TM1 and TM4 in the three states of the receptor.
Thus, in 5-HT, LSD, and KET trajectories TM4 forms angles of
12u,1 6 u and 22u, respectively, with the membrane normal z axis;
TM1 tilts so that in KET-bound compared to 5-HT-bound
receptors its EC end is 3 A ˚ closer to TM7 and its IC side is 1.5 A ˚
farther from TM7. The differences in conformational changes of
TM1 are consistent with the available X-ray structures of the
activated GPCR, where a repositioning of the IC end of TM7
towards TM1 is reported in active b2AR [23] and opsin structures
[20,21]. As discussed below, these tilt differences in TM1 and
TM4 are reflected in the response of the membrane to the
interaction with the protein, and thereby can affect the ligand-
regulated oligomerization of the 5-HT2AR.
The nature of the changes occurring in the transition from the
‘‘activated’’ 5-HT-bound state of the receptor, to the KET-bound
‘‘inactivated’’ state, is evidenced by the application of Comb-ED
analysis to combined trajectories involving the KET-substituted
simulation (started from an equilibrated 5-HT-bound receptor)
(Figure 5B). Separately, two Comb-ED analysis were performed:
One comparing the last 100 ns from the KET-substituted and the
original KET-bound simulations, and the other comparing the
KET-substituted and the 5-HT-bound simulation. The projec-
tions along the first eigenvector of these combined trajectories
(Figure 5B) reveal the internal consistency of the results and show
that, upon KET substitution, the 5-HT2AR structure deviated
from the 5-HT-stabilized conformation and became similar to that
stabilized by KET in our earlier simulation, with TM4 and TM6
helices changing the most. Consistent with the results in Figure 6,
in the KET-substituted simulation the IC end of TM6 moved
towards TM3, and TM4 became tilted.
In addition to Comb-ED analysis of pair-wise concatenated
trajectories, we applied Comb-ED as well to all four trajectories (5-
HT, LSD, KET, KET-substituted) concatenated together. The
results (Figure S3 in Text S1) clearly show that KET-substitution
transitions the receptor from the conformational states visited by
5-HT to those most visited when KET is bound in the receptor.
Ligand-dependent conformational changes in the
receptor elicit corresponding structural re-arrangements
in the surrounding lipid membrane
From the results of the comparative simulations we have
identified two mechanisms of membrane re-organization in
Figure 6. Comb-ED analysis of the conformational spaces visited by 5-HT2AR bound to 5-HT, LSD and KET. (A) Projections along the
first and second eigenvectors obtained from the Comb-ED analysis on the concatenated 5-HT-LSD (upper panel), 5-HT-KET (middle panel), and LSD-
KET (lower panel) trajectories. The centers of the conformational space sampled by ligands are in black dots and are connected by black dotted lines.
(B) Extreme projections along the first eigenvector of the combined 5-HT-LSD (top panel), 5-HT-KET (middle panel) and LSD-KET (bottom panel)
trajectories. The receptor is rendered and colored as in Figure 5B. (C) Comparison of the 5-HT2AR structures in complex with 5-HT, LSD or KET
averaged over the final 100 ns aligned with seven most conserved residues in each TM [18]. The receptor structures in complex with different ligands
are shown in cartoon and are colored as in panel A.
doi:10.1371/journal.pcbi.1002473.g006
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dynamics of the ligand-bound receptor: (i)-the direct interactions
of the receptor with the Cholesterol (Chol) constituent of the
membrane, and (ii)-the deformation of the membrane around the
GPCR, which modulates the local thickness of the bilayer and the
hydrophobic mismatch that can drive oligomerization of the 5-
HT2AR [32].
Cholesterol interacts with the structural elements of
GPCR activation. Cholesterol has been implicated in GPCR
function and activation [44] and shown to bind to preferred sites
of rhodopsin in extended simulations of this GPCR in lipid
membranes [43]. Here we found that the regions ranked highest in
Chol population during the simulation of the 5-HT2AR were the
IC end of a TM bundle including TMs 1, 2 and 4; the EC ends of
TMs 2 and 3; and the EC and IC ends of TMs 6 and 7 (see Table
S1 in Text S1). Notably, these sites were also found to be the areas
of high Chol-density in earlier studies on rhodopsin [43,45,46], as
well as in a 250 ns simulation of rhodopsin in a membrane with
the same lipid composition as used here (SDPC/POPC/Chol - see
[32]). We hypothesized, therefore, that Chol binding at these
preferred locations may have some functional importance
observable through effects on the monitored SM/FMs. Given
the prominent structural changes in TM6 observed in our
simulations of the 5-HT-bound 5-HT2AR, this hypothesis was
investigated for Chol at the IC and EC ends of TMs 6 and 7.
Figure 7 summarizes Chol dynamics around the EC and IC
ends of TMs 6 and 7, and its relation to the activation elements in
5-HT-bound receptor. The Chol at the EC end of TM6 is seen to
be in direct contact with residues M6.57, I6.60, and C6.61 at the
initial stages of the simulation (Figure 7A, upper panel), and to move
away from these residues within the first 40 ns (Figure 7B).
Interestingly, during the same time interval, we observe changes in
one of the identified SM/FMs, as TM6 straightens out at the EC
end, and starts moving towards TM3 (cf. Figures 2–3). Near the
140 ns time-point, another Chol, initially in contact with the IC
end of TM7, moves towards TM6 and establishes interactions
with residues K6.35, I6.39, F6.42 and V6.46 (Figure 7A, middle and
lower panels, and Figure 7C). Remarkably, this shift of Chol away
from TM7 and toward TM6 coincides with the time when the
toggle switch W6.48 flips (Figures 2–3), and TM6 starts to bend
away from TM3 at the IC end (Figures 2–3). Thus, the time
dependence of Chol dynamics at the IC and EC ends of TM6 suggests its
participation in the development of the activated conformation in the agonist-
bound 5-HT2AR.
To quantify the apparent correlation between the Chol
dynamics and the structural changes in the 5-HT/5-HT2AR
simulation we calculated the Pearson correlation coefficients
between the dynamic quantities presented in Figures 3 and 7,
and constructed the matrix of the corresponding Pearson R
2 scores
following a protocol described earlier [43]. The strong correlation
between Chol-TM6 distances and agonist-induced changes in 5-
HT2AR is evident from the high values of the correlation
coefficients (Figure 7D) calculated for the MD trajectory.
Notably, the pattern of Chol-GPCR interactions around TM6
in the 5-HT/5-HT2AR trajectory is different from those observed
in either the LSD-bound or the KET-bound receptor. For
example, analysis of the KET simulation shows a single Chol
around the IC ends of TM5 and TM6 (Table S1 and Figure S4 in
Text S1). This Chol molecule is engaged in interactions with F6.42
and V6.46, the same two residues of TM6 that we found to
interact as well with Chol in the 5-HT trajectory (see Figure 7). But
in contrast to the 5-HT simulation, the cholesterol positioned near
Figure 7. Cholesterol dynamics correlates with the structural transitions in agonist-bound 5-HT2AR. (A) Evolution of the minimum
distances between the Chol at the EC end of TM6 and selected TM6 residues in the 5-HT simulation (top panel). Time traces of the minimum
distances between the Chol at the IC ends of TM6–7 and selected residues on TM6 and 7 (middle and bottom panels). The Chol initially in contact
with the L7.44, V7.48, V7.52, and L7.55 residues on TM7 moves towards TM6 and engages in interactions with the residues K6.35, I6.39, F6.42, and
V6.46 on TM6. (B) Snapshots at 10 and 30 ns showing the Chol from the top panel of (A) interacting with EC TM6. (C) Snapshots at 50, 167.6 and
250 ns showing the Chol from the bottom panels of (A) interacting with either IC TM6 or IC TM7. (D) Matrix of Pearson’s score tests performed on the
dynamics quantities presented in the top panel of (A) and on the bend (‘‘B’’) and face-shift (‘‘FS’’) angles around P6.50 and P7.50 (top panel). Matrix of
Pearson’s score tests performed on the dynamic quantities presented in middle and bottom panels of (A) and on the bend (‘‘B’’), and face-shift (‘‘FS’’)
angles of P6.50 and P7.50 (bottom panel).
doi:10.1371/journal.pcbi.1002473.g007
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residues from TM5: F5.59 and I5.62. The specificity of these
interactions is suggested by the observation that in the KET-
substitution simulation (initiated from the 5-HT-induced confor-
mation of the receptor), Chol interactions rearrange to the pattern
observed in the regular KET simulation. Thus, in the KET-
substitution simulation Chol still interacts initially with F6.42,
V6.46, and I6.39, but when the ionic lock starts to form, F6.42
flips (without loosing contact with the cholesterol) towards TM5
and establishes stable interactions with F5.59 that brings TM5 and
TM6 helices together from the IC side. Similarly, in the KET
simulation, cholesterol near TM5 and TM6 appears as well to
bring these two helices together by forming a bridge between
F6.42 and F5.59.
When considered together with the ionic lock data (Figure 4), these results
suggest an active involvement of cholesterol near the IC end of TM6 in
establishing differential ligand-induced conformational dynamics of the receptor.
Membrane shape exhibits distinct patterns in response
to the 5-HT2AR conformations attained by
pharmacologically different ligands
The distinct conformational changes in the receptor produced
by the binding of the different ligands (see above) produce different
patterns of bilayer deformations around the receptor protein in
complex with the different ligands (Figure 8). This difference is a
result of the tendency of the lipids to minimize the hydrophobic
mismatch at various TMs, i.e., the difference in the hydrophobic
lengths presented to the membrane by the corresponding TMs in
the different receptor complexes (see detailed discussion in [32]).
Therefore, hydrophobic thickness profiles of membranes around
5-HT2AR in the simulated complexes with 5-HT, LSD, and KET,
shown in Figure 8, reveal remarkable differences in the membrane
organization around individual TMs in the three systems. For
example, the membrane appears thinner around TM4 and TM6
in 5-HT (left panel) than in the KET simulation (right panel), whereas
at TM1 the bilayer is thicker in the LSD (middle panel) than in the
complexes with 5-HT or the KET.
We have developed a quantitative method (CTMD), for the
analysis of such membrane deformations and the significant
residual exposure to unfavorable hydrophobic-hydrophilic inter-
actions at specific TMs that results from an incomplete alleviation
of the hydrophobic mismatch [32]. When applied to the 5-HT2AR
complexes discussed here, residual exposure [32] was found at
TM4 for all three complexes, although the values were different
possibly because the TM4 tilt is different in the KET, LSD and 5-
HT trajectories (see above). Because the extent of the hydrophobic
mismatch around the TM helices is considered to be a driving
force for oligomerization [32,47,48], we had compared the
residual exposure energies at all TMs in the simulation results
for the three complexes. At TM1 it was found to be substantial
only in the KET simulation, consistent with the conformational
changes we observed for TM1 in different systems (see above), and
at TM5 it appeared to be relatively similar in all three complexes,
but somewhat more pronounced in the 5-HT-bound structure;
lastly, the residual exposure at TM6 is largest as well in the 5-HT
trajectory, possibly due to the relatively straighter configuration of
this helix in the 5-HT simulation (Figures 3–4). One possible
mechanism to reduce the energy penalty for this residual exposure
in the membrane-embedded receptor conformation produced by
the binding of a particular ligand, is to bring together the TM
domains where the residual exposure is largest. Therefore, we
proposed [32] that this represents a membrane-determined energy
drive for the association of the proteins in the membrane.
Consequently, our data in Table 2 of [32] suggests that if the
hydrophobic mismatch is the driving force for receptor oligomer-
ization, then the contact interfaces for oligomerization of the 5-
HT2AR will be different in the complexes with 5-HT, LSD, or
KET. According to this mechanism, ligands will not only regulate
the extent of GPCR oligomerization, but will also influence which
TM domains constitute the oligomerization interface. Thus, a
comparison of residual surface area values at different TMs in 5-
HT, LSD, and KET simulations implicates TM1, TM4 and TM5
as likely participants in the oligomerization interface of 5-HT2AR
in complex with KET, TM4 and TM5 in the oligomerization
interface of LSD-bound receptors, and TM5 (and possibly TM6,
Figure 8. Hydrophobic thickness profiles of simulated membranes around 5-HT2AR in complex with 5-HT, LSD, or KET. The structures
of the various ligand-bound receptor structures averaged over the last 100 ns of the simulations are shown in cartoon, with only the helices depicted
(in different colors) with corresponding TM numbers. The colored fields represent distances (in A ˚) between lipid backbone C2 atoms from the
opposing leaflets. For this analysis, for each simulated system the membrane plane was divided into square 2 A ˚62A ˚ bins, and the average C2-C2
distances in each bin were collected by scanning the last 100 ns of trajectory.
doi:10.1371/journal.pcbi.1002473.g008
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oligomerization of 5-HT-bound serotonin receptor.
In addition, the results in Table 2 of [32] for the 5-HT and
KET simulations imply that overall the inverse agonist KET will
promote more extensive hydrophobic mismatch-driven oligomer-
ization, since the residual surface area value summed over all TMs
is about 90 A ˚ 2 higher for KET-bound 5-HT2AR than it is for 5-
HT-bound receptor. This prediction is in excellent agreement
with the experimental data on ligand-regulated oligomerization on
b2AR [31], where in comparison to the agonist isoproterenol, the
binding of an inverse agonist was suggested to promote tighter
packing on b2AR protomers and/or to result in formation of
higher-order oligomeric structures.
With regard to the validation of the ligand-dependent dynamic
properties, it is important to note that similar residual exposure is
observed in the two KET-bound simulations starting from very
different initial conformations. Thus, the trend of large residual
exposures at TM1, TM4, and TM5 of the KET system is also
observed in the KET-substituted system (Table S3 in Text S1).
Moreover, near the TMs where the hydrophobic mismatch
is alleviated by the membrane remodeling (e.g., TM6), the
membrane has similar thickness in both the KET and KET-
substituted system (Figure S6 in Text S1).
Discussion
The MD simulations of the 5-HT-, LSD- and KET-bound 5-
HT2AR reported here provide the first molecular representation of
the different effects that pharmacologically distinct ligands can
have on the 5-HT2AR. The concepts of ‘‘functional selectivity’’
[49,50] and ‘‘receptor bias’’ [51] are frequently being used to
explain the increasingly common observation of differential re-
sponses elicited by different ligands from the same receptor (e.g.,
for 5-HT2AR see [4,52]). However, no structural context had been
identified for the distinct effects on the dynamics produced in the
same GPCR by the binding of pharmacologically different ligands.
Here we simulated the dynamics of the 5-HT2AR binding of such
pharmacologically distinct ligands, and identified different effects
on the SM/FMs of the receptor. These effects were shown to lead
to different rearrangements that correspond to the different levels
of activation known to be produced by these ligands. Notably,
the differential effects were shown to be consonant with the
pharmacological characterization of the three ligands as a full,
partial and inverse agonist, respectively. To our knowledge, such
inferences were obtained for the first time here from unbiased
atomic MD simulations, but they are in line with the increasingly
detailed experimental evidence about ligand-related functional
selectivity [49,50,51,53,54,55,56,57,58,59,60,61,62,63,64,65,66],
with the proposals of ligand-selective conformations in the 5-
HT2AR [67] and the D2R [68], and with structural data indicating
that GPCRs such as b2AR are stabilized in distinct conformational
states by inverse, partial, or full agonists - respectively [12,13].
In the current simulations, structural changes associated with
SM/FM characteristics of an ‘‘activated state’’ of the 5-HT2AR
appear in sub-microsecond trajectories. In contrast, experimen-
tally determined GPCR activation timescales generally vary from
microseconds (photoactivation of rhodopsin [69]) to seconds
(b2AR in living cells [70]). We emphasize that the conclusions
reached here do not require the simulations to have converged to
an ‘‘active state structure’’ of the kind claimed for the constructs
determined crystallographically. Indeed, a number of modes of
activation proposed from experiment share this characteristic and
can also be significantly faster [71,72,73]. But in general, there are
many reasons for the time scale differences between our results
and functional measurements. In particular, the simulated system
is an idealized construct in that all interaction components are
placed in optimal positions to be at or near their targets. Titratable
groups are also assigned their final charge states, e.g., when the
D3.49 and E6.30 are in the protonated form in some of the
constructs. Interestingly, the specific protonation form does not
determine whether the ionic lock is formed or not (see Figures 3–4,
and Figure S5 in Text S1); rather, the determinant factor is seen
from our results to be the nature of the dynamics induced by the
binding of a specific ligand. But considering that inactive GPCR
(b2AR) may be pre-coupled to G-protein Gs [31] and the pro-
tonation of E3.49 in rhodopsin (an activation step) depends on
transducin [74], the degree of precoupling will likely play a role in
the activation time. Moreover, the simulation conditions (such as
pH, salt, lipid composition, and crowding) certainly do not mimic
completely those surrounding the receptor in living cells (e.g., it is
known that the highly flexible DHA chain of SDPC, included in
the lipid mixture used here, facilitates GPCR activation [75]),
and similar time-scale differences have been observed between
computer simulations and experiments for other GPCRs [76,77].
The response of the membrane environment to the different
ligand-induced structural re-arrangements produces a reorganiza-
tion of the membrane around the receptor. This is reflected in (i)-
the involvement of Chol in direct interactions with the protein
[43,78], that was shown here to affect the dynamics of the SM/
FMs, and (ii)-the membrane deformations around the TM bundle
of a GPCR [48,79], described here with the use of the CTMD
method [32]. Because the different ligand-determined conforma-
tional changes in 5-HT2AR establish different patterns of local
perturbations in membrane structure around the receptor complex,
they were suggested to promote different ligand-dependent re-
ceptor oligomerization patterns through the hydrophobic mismatch
between the TMs and the surrounding membrane [32]. This is
supported by observations in the literature that: (i)- oligomeric
associations of the dopamine D2R [27], 5-HT2CR [28], and the
b2AR [31] is ligand-sensitive; and (ii)- GPCR self-assembly is
regulated by the mismatch between the hydrophobic length of the
TM segments of GPCRs and the hydrophobic thickness of the lipid
bilayer, as suggested by both experimental results [80] and
computational studies for rhodopsin [32,48,79]. Along these lines,
the results presented here suggest that the dimerization interfaces of
5-HT2AR oligomers will be different for inverse agonist-, partial
agonist-, or agonist-bound complexes, and moreover that the
inverse agonist KET would promote more extensive 5-HT2AR
oligomerization than the full agonist (5-HT). We note that these
experimentally testable predictions regarding possible oligomeriza-
tion interfaces were obtained by analyzing monomeric GPCRs in
complex with different ligands, without the need to simulate the
dimers or higher oligomers.
Methods
Construction of the simulated systems
Several model systems of the serotonin 5-HT2AR receptor were
studied with all-atom MD simulations in explicit models of the
hydrated lipid membrane environment. The 5-HT2AR was
simulated in complex with three ligands known to exhibit different
pharmacological efficacies: the full agonist 5-HT, the partial
agonist LSD, and the inverse agonist KET (Figure 2A).
5-HT2AR constructs. For the simulation of 5-HT bound 5-
HT2AR, the protein was modified twice, very slightly, in regions
distal to the binding site and the SM/FMs. The original receptor
construct had a specific truncation of IL3 so that it consisted of 296
residues, from H1.28 to D5.57 and from R6.21 to K7.73, with an
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where ‘‘–’’ denotes truncation). To match observations in crys-
tallographic structures of several GPCRs [20,25,81], we thus
added, at 112.5 ns, four residues to the IL3 (H1.28–L5.79–AA–
S6.17–K7.73) in order to extend helical parts of TM5 and TM6,
respectively, by two turns. The extension was done as follows:
an average structure of the protein (including the ligand and
palmitoyl derivative) was obtained from the trajectory between
from 83.5 to 112.5 ns. The averaged structure was minimized first
with constrained protein backbone and ligand heteroatoms
followed by minimization without constraints. To enhance the
flexibility of the truncated IL3, we extended the intracellular ends
of TM5 and TM6 by 2 turns of helix each using Modeller [82],
and selected the representative model by clustering the 100 models
using either the extended TM5 or TM6. The loop between the
extended TM5 and TM6 was refined using Modeller. The protein
with extended TM5 and TM6 together with the ligand and
palmitoyl chain was minimized first with protein backbone and 5-
HT heteroatoms constrained, followed by complete minimization.
The minimized complex was inserted in the lipid/water/ion
environment from the snapshot at 112.5 ns to conserve
interactions, after which the entire system was minimized and
equilibrated with constraints on the protein backbone (velocities
were reassigned in a random distribution based on the
temperature). For the second extension, at 174.2 ns (i.e., 61.7 ns
after extending TM5 and TM6), we added three more residues at
the N-terminus (S1.25–L5.79–AA–S6.17–K7.73) to allow TM1 to
reach beyond the lipid phosphate group region of the model
membrane so as to avoid artificial interactions between the
positive N-terminus and negative phosphate groups in membrane
lipids. In addition, the N-terminus was acetylated and the C-
terminus was N-Methylamidated to further avoid charge-charge
interactions between termini and lipids. The simulations were then
continued and the results reported here are from the 350 ns
trajectory. Note that the initial homology model of 5-HT2AR
includes an artificially open ‘‘ionic lock’’ between residues R3.50
and E6.30 due to the use of the b2 adrenergic receptor (b2AR)
template in the homology modeling [83]. In the b2AR X-ray
structure [45] the ionic lock is broken due to the co-crystallized
lysozyme, but has been shown to consistently reform in MD
simulations of inactive b2AR without the lysozyme [40].
The simulations of LSD-bound and KET-bound 5-HT2AR,
started from the same conformation as for the 5-HT bound 5-
HT2AR except that they included the extensions from the very
beginning. In addition, to test whether KET, as an inverse agonist,
is capable of reversing the conformation induced by the bound
agonist 5-HT, we substituted 5-HT with KET in the activated 5-
HT2AR structure obtained at the end of the 5-HT simulation, and
restarted that simulation with KET for an additional 500 ns
(termed ‘‘KET-substituted simulation’’). The protocol for this
switch of ligand was as follows: (i)-An average structure
(protein+5HT+palmitoyl chain) was generated using the last
50 ns of 5-HT simulations, and then minimized; (ii) 5HT was
substituted by KET so that the docking pose of KET (Figure 2D,
left panel) is aligned with the minimized average structure using
backbone atoms of binding site residues: D3.32, S3.36, S5.42 and
S5.46. The complex (protein+KET+palmityol chain) was mini-
mized by fixing the heteroatoms of KET and constraining
backbone atoms of the protein; (iii)-The minimized complex was
combined with the lipid/water/ion environment from a snapshot
at 350 ns of the 5-HT simulation, to conserve the interaction
between the protein and the environment. Lipid/water/ion was
minimized and then equilibrated. Finally the whole system was
equilibrated by reducing constraints on protein backbone atoms
and KET heteroatoms. Velocities were reassigned based on the
temperature.
Residues D3.49 and E6.30 were protonated in the 5-HT and
LSD simulations (see also Discussion section, above), and
deprotonated in the KET simulations (including KET-substituted
simulation). We note that the protonation state of the E6.30
residue does not affect the state of the ionic lock, as we show in the
separate simulation of KET-bound 5-HT2AR where E6.30 residue
is protonated (see Figure S5 in Text S1).
In all simulations, C7.70 was palmitoylated by moving the
coordinates of the palmitoyl chain (PALM) from PDB 2RH1 [45]
onto the C7.70 of 5-HT2AR.
Loop structures determined from ab inito loop pre-
diction. To enable full-scale 5-HT2AR simulations, we refined
the loops in 5-HT2AR homology model described recently [83]
using the Monte Carlo-Scaled Collective Variables ab initio method
[84,85]. For details see Methods and Table S2 in Text S1.
Initial placement of the ligands. Protonated 5-HT, LSD
and KET were docked into 5-HT2AR using several docking
protocols, including Autodock 4 [86], Simulated Annealing-
Docking [87], Glide (Schro ¨dinger Inc.), and IFD (Schro ¨dinger
Inc.). In Autodock, the GA-LS algorithm and a maximum number
of 2.5610
7 evaluations were used. Simulated Annealing-Docking
was carried out following a protocol previously established in our
lab [87,88] starting from a binding pose of 5-HT predicted by
Autodock and consistent with experimental data. Glide [89] was
carried out with and without H-bond constraints on D3.32 and/or
S5.46. Applying H-bond constraints on S5.46 generated more
docking poses that were consistent with the experimental data.
IFD [90] was carried out starting either from scratch or from Glide
docking poses that were consistent with experimental data. Other
docking parameters were set to default values.
These procedures generated docking poses consistent with
experimental data in the literature [2,6,7,91,92] (Figure 1A–D). In
particular, for KET, IFD produced a cluster of docking poses in
which the amines of the ligands interacted with D3.32 and S5.46,
and its quinazoline ring immersed deep into the binding pocket
close to W6.48. The binding site remained almost unchanged
except that F6.52 rotated to avoid steric clashes with KET
(Figure 1D). In this docking pose, which was used in the
simulations, KET was in direct contact with the aromatic cluster
(F5.47, F6.44, W6.48, F6.51 and F6.52) by forming an edge-to-
face interaction with W6.48.
Internal waters. X-ray structures of several GPCRs show
water networks around the toggle switch W6.48 and the NPxxY
motif [45,93,94,95], and these are hypothesized to be important
for receptor activation [96]. Internal waters were therefore
introduced by solvating the 5-HT2AR with Grand-Canonical
Ensemble simulations using the Monte Carlo program MMC [97].
The procedure placed waters around W6.48 and the NPxxY motif
consistent with the X-ray structures of cognate GPCRs.
Lipid membrane composition and protein-membrane
complex preparation. The 5-HT2AR-ligand complexes were
embedded in identical mixed and hydrated 7:7:6 1-stearoyl-2-
docosa-hexaenoyl-sn-Glycero-3-phosphocholine (SDPC)/phos-
phatidylcholine (POPC)/Chol membranes. The choice of the
lipid mixture was dictated by several factors: (i)-Chol is known
to be important for modulating ligand binding, G-protein
binding and activation of serotonin receptors [44], and has even
been found in complex with the X-ray structures of amine
GPCRs elucidated recently; (ii)-POPC represents a typical
phospholipid component of the bilayer membrane, with one
saturated and one mono-unsaturated acyl chain; and (iii)-SDPC
lipid has been implicated specifically in the function of various
Ligand-Dependent Differences in 5-HT2AR States
PLoS Computational Biology | www.ploscompbiol.org 11 April 2012 | Volume 8 | Issue 4 | e1002473GPCRs [98] and is abundant in neuronal tissues. In addition,
the use of this lipid composition enables a comparison of Chol
dynamics around 5-HT2AR with observations from earlier MD
studies of rhodopsin in somewhat different Chol-containing
mixed membranes [43].
The lipid bilayer model was generated using VMD [99] to
construct first a 120 A ˚6120 A ˚ (in the x-y plane) hydrated POPC
membrane patch consisting of 406 lipids; then, half of the POPC
lipids were transformed to SDPC by translating corresponding
atoms, i.e., from the POPC headgroups to PCGL, from the 16:0
sn-1 chain to STEA, and from the 18:1 sn-2 tail to DHA (missing
atoms were built using internal coordinates in the all-atom
CHARMM27 force field [100] with CHARMM31b1 [101]). To
reduce steric clashes between POPC and SDPC molecules,
we made use of the relatively straight DHA chains from the
equilibrated SDPC membrane bilayer (http://www.lipid.wabash.
edu/), and replaced all the DHA chains in the current membrane
patch with the straight DHAs. The 5-HT-, LSD-, or KET-bound
5-HT2AR were inserted into the lipid matrix by aligning the
backbone of its seven most conserved residues (one in each TM,
see [18]) with those of rhodopsin immersed in a POPC membrane
[22]. Lipids within 0.8 A ˚ of the protein and PALM were then
removed leaving 354 lipids in total. 26 SDPC and 26 POPC in
each leaflet were randomly replaced with Chol (PDB 3D4S [46]),
by fitting Chol’s C4, C5 and C6 atoms to STEA’s C5, C6 and C7
or POPC’s C35, C36 and C37. Chol positions were then refined
by lateral translation to avoid clashes with other Chol, SDPC or
POPC lipids. Finally, the systems were solvated with TIP3 water
and 0.15 M NaCl salt. The final simulated systems consisted of
125 SDPC, 125 POPC, 104 Chol and 20–22K water molecules
resulting in a total of 106–114K atoms.
Force-fields and MD simulations
The parameters for 5-HT were taken from an earlier study [7].
For LSD and KET, the results of geometry optimization and
electrostatic potentials obtained from quantum mechanical
calculations with the Gaussian program (Gaussian, Inc., Wall-
ingford, CT) were used as input to the Restrained-ElectroStatic-
Potential fit method [102] implemented in Antechamber [103] to
derive charges. CHARMM topology and parameter files were
then prepared with Antechamber using Restrained-ElectroStatic-
Potential charges and GAFF force field. Force field parameter files
for 5-HT, LSD and KET are included in Text S1. For protein,
PALM, lipids etc., the all-atom CHARMM27 force field with
CMAP corrections [100] was utilized (this approach is similar to a
procedure used successfully in previous studies [104,105]).
All MD simulations were performed with the NAnoscale
Molecular Dynamics (NAMD) suite [106]. As established in
similar studies in the lab (e.g., see [107]), the simulations were
conducted under constant temperature and pressure conditions
with anisotropic pressure coupling, and utilized PME for long-
range electrostatics [108]. The Nose-Hoover Langevin piston
method [106] was used to control the target pressure with the
LangevinPistonPeriod set to 100 fs and LangevinPistonDecay set
to 50 fs. All MD simulations were performed with rigidBonds
allowing 2 fs time step.
All the simulated systems were equilibrated following a
procedure described recently [109]. According to this protocol,
the 5-HT2AR backbones and the heavy atoms of the ligands were
initially fixed and then harmonically constrained, and water was
prevented from penetrating the protein-lipid interface. Constraints
were released gradually in four 300 ps-step MD simulations with
decreasing force constants of 1, 0.5, 0.1 and 0.01 kcal/(mol?A ˚ 2),
respectively. Following this equilibration phase, all three GPCR-
membrane complexes were simulated for 350 ns.
The stability of the simulated complexes was monitored from
the backbone RMSDs of the TMs in 5-HT2AR using the following
definitions for TMs: L1.29–L1.59, A2.38–Y2.67, L3.24–N3.56,
S4.38–V4.62, D5.35–K5.67, N6.29–I6.60, G7.32–F7.56 and
K7.58–I7.68. As illustrated in Figure 1E, after initial equilibration,
the RMSDs in all the three systems were stable and fluctuated
around or below 2 A ˚. In all three simulations the ligands
maintained key interactions with the receptor (Figure 1B–E),
consistent with previous experimental data [2,6,7,91,92].
Analysis of MD trajectories
To quantify the changes in protein structure produced by the
simulations we used various analysis tools. Analysis of protein
structural data was carried out with Ptraj in AMBER 9 [110] and
other tools discussed below. To quantify helix distortion
parameters in the simulations, we used the Prokink package
[111] implemented in Simulaid [112]. The correlation analysis on
the time-dependent data of different variables, such as helix bend
angles, face-shifts, as well as Chol-protein distances, was conducted
following the procedure described in [43]. Briefly, the correlation
analysis was carried out on two separate sets of dynamic variables.
In the first, we followed the time-sequence of m=8 selected
variables that included proline kink and face-shift angles in TM6
and TM7, the minimum distances between the Chol at the EC
end of TM6 and the residues on TM6 (I6.53, M6.57, I6.60,
C6.61). In the second set, m=12 dynamic variables were selected
that included proline kink and face-shift angles in TM6 and TM7,
the minimum distances between the Chol at the IC end of TM6–7
and the residues on TM6 and TM7 (K6.35, I6.39, F6.42, V6.46,
L7.44, V7.48, V7.52, L7.55, F7.56).
For each set, we first studied pair-wise correlations between
different variables, and constructed the matrix of coefficients of
determination, R
2 (Figure 7D of the main text) using Spearman’s
rank correlation test (see for instance Ref. [113]). In this method,
given Nframes pairs of observations, (xi, yi), first the xi and yi values
separately are assigned a rank, and then the corresponding
difference, di between the xi and yi ranks is found for each pair.
The R
2 is then defined as:
R2~
XNframes
i~1 d2
   2
ð1Þ
Because it uses rankings, Spearman’s method eliminates the
sensitivity of the correlation test to the function linking the pairs of
values and thus is preferred over parametric tests when no a priori
knowledge exists on the functional relationship between xi and yi
pairs.
Combined Essential Dynamics (Comb-ED) analysis
To compare the conformational spaces of 5-HT2AR stabilized
by the different ligands (i.e., 5-HT, LSD and KET), a Combined
Essential Dynamics analysis [42,114] was performed on Ca atoms
of the protein using Gromacs 3.3 [115]. Essential dynamics
analysis separates the configurational space into an essential
subspace with a few degrees of freedom which describe overall
motions of the protein that are likely to be relevant to its function,
and a physically constrained subspace describing local fluctuations.
The method is based on the diagonalization of the covariance
matrix of atomic fluctuations defined by:
Cij~S xi{SxiT ðÞ xj{SxjT
  
T ð2Þ
Ligand-Dependent Differences in 5-HT2AR States
PLoS Computational Biology | www.ploscompbiol.org 12 April 2012 | Volume 8 | Issue 4 | e1002473where xi are the three Cartesian coordinates of the carbon atoms
Ca of the molecule under study, and the angular brackets denote
averages over an ensemble of configurations and over the sim-
ulation time. The diagonalization of Eq. (3) yields eigenvectors
that describe the directions of correlated positional changes in the
molecule, whereas the eigenvalues indicate the total mean square
fluctuation along these directions.
In the Comb-ED, the covariance matrix is calculated for two or
more concatenated trajectories, which are fitted on the same
reference structure. Given this construct, the eigenvectors resulting
from Comb-ED do not represent the essential degrees of motion of
the molecules, but rather reveal differences and/or similarities in
the dynamical and structural characteristics of the compared
simulated structures. To identify structural differences between 5-
HT2AR stabilized by the three ligands, Comb-ED analysis was
performed on 3 concatenated trajectories obtained by combining
the trajectories for the pairs 5-HT-LSD, 5-HT-KET, and LSD-
KET, each for the last 100 ns, respectively.
Analysis of membrane deformations and the residual
mismatch. The properties of the membranes were analyzed
from the simulation trajectories using the recently described
CTMD method [32]. Briefly, to quantify membrane deformations
in the simulations and the hydrophobic mismatch energies, we
calculated the time-averaged hydrophobic thickness profile of the
membrane surrounding 5-HT2AR in all trajectories and used
solvent accessible surface area calculations to calculate the energy
of the residual mismatch which exposes TM residues participating
in unfavorable interfacial hydrophobic/hydrophilic interactions.
To identify these residues, we determined if the TM is thicker or
thinner than the surrounding membrane by comparing the
hydrophobic thicknesses of the TM domains (using the following
TM definitions (given in the Ballesteros-Weinstein generic
numbering [18]): 1.29–1.59 (TM1), 2.38–2.67 (TM2), 3.24–3.53
(TM3), 4.39–4.63 (TM4), 5.38–5.63 (TM5), 6.33–6.59 (TM6),
7.30–7.56 (TM7)) to the local membrane thickness dmemb calculated
from the membrane sectors corresponding to each TM, as
described in [32].
Supporting Information
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